biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > 3 shares traded? Am I reading that right?

<< Previous

Bullboard Posts

Next >>

Comment by chrispion Mar 22, 2021 12:27pm

131 Views

Post# 32850672

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:3 shares traded? Am I reading that right?

quality over quantity.

To help you understand that concept ... I'd rather have 1 "Domaine de la Romane-Conti Romane-Conti Grand Cru" bottle of wine compared to the 10k "Bud Light" beers you'd prefer.

Come on over and we'll toast a cheer (with different drinks of course as explained above) to the anticipated great news in the coming months for Bioasis!

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project